Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom

Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom

Intrahepatic cholangiocarcinoma (iCCA) patients had no obvious symptoms at early stage and poor postoperative survival. Therefore, the establishment of an iCCA prognostic prediction model to carry out refined management of iCCA patients is expected to improve the survival of the iCCA patient populat...

Full description

Bibliographic Details
Main Authors:	Guodong Shi, Junjie Wang, Weiqi Wang, Min Chen, Xiaoxuan Liu, Yufan Zheng, Yi Fu, Minghua Wang, Xiaojie Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Genetics
Subjects:	intrahepatic cholangiocarcinoma N6-methyladenosine long non-coding RNA gene co-expression network prognostic signature
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.982707/full

Similar Items

Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival
by: Nimish Thakral, et al.
Published: (2023-05-01)

A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma
by: Wenbo Zou, et al.
Published: (2021-05-01)

Imaged periductal infiltration: Diagnostic and prognostic role in intrahepatic mass-forming cholangiocarcinoma
by: Kenichiro Okumura, et al.
Published: (2024-06-01)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
by: Yujia Chen, et al.
Published: (2022-03-01)

Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma
by: Yao Xinfei, et al.
Published: (2022-09-01)

A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses in intrahepatic cholangiocarcinoma detected by single-cell RNA sequence analysis
by: Hefei Ren, et al.
Published: (2024-03-01)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
by: Di Zheng, et al.
Published: (2022-02-01)

Preoperative prognostic nutritional index predicts postoperative infectious complications and oncological outcomes after hepatectomy in intrahepatic cholangiocarcinoma
by: Tatsuo Matsuda, et al.
Published: (2021-06-01)

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
by: Kun-Ming Chan, et al.
Published: (2018-12-01)

PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinoma
by: Wenbo Zou, et al.
Published: (2021-12-01)

NRP1 is a Prognostic Factor and Promotes the Growth and Migration of Cells in Intrahepatic Cholangiocarcinoma
by: Wu YN, et al.
Published: (2020-08-01)

iNOS is Associated with Tumorigenicity as an Independent Prognosticator in Human Intrahepatic Cholangiocarcinoma [Retraction]
by: Liu S, et al.
Published: (2023-08-01)

Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
by: Chun-Yi Tsai, et al.
Published: (2022-03-01)

Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients
by: Xin Huang, et al.
Published: (2022-08-01)

Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma
by: Lin J, et al.
Published: (2019-10-01)

Construction of a Prognostic Signature of 10 Autophagy-Related lncRNAs in Gastric Cancer
by: Wang W, et al.
Published: (2022-04-01)

Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma
by: Zhenyang Shen, et al.
Published: (2020-10-01)

Sarcomatoid change in intrahepatic cholangiocarcinoma
by: Albrechtsen Wewer Nicolai, et al.
Published: (2013-03-01)

SARCOMATOID CHANGE IN INTRAHEPATIC CHOLANGIOCARCINOMA
by: Wewer Albrechtsen, et al.
Published: (2013-01-01)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
by: Yoshiyuki Inoue, et al.
Published: (2012-01-01)

Development and Validation of a Radiomic-Based Model for Prediction of Intrahepatic Cholangiocarcinoma in Patients With Intrahepatic Lithiasis Complicated by Imagologically Diagnosed Mass
by: Beihui Xue, et al.
Published: (2021-01-01)

A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass
by: Chen G, et al.
Published: (2018-04-01)

Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma
by: Wentao Lin, et al.
Published: (2024-02-01)

The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
by: Hua Yu, et al.
Published: (2020-01-01)

Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma
by: Georgios Charalampopoulos, et al.
Published: (2023-06-01)

Feasibility of machine learning-based modeling and prediction using multiple centers data to assess intrahepatic cholangiocarcinoma outcomes
by: Shuang-Nan Zhou, et al.
Published: (2023-12-01)

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
by: Danjun Song, et al.
Published: (2023-03-01)

Resection of intrahepatic cholangiocarcinoma in elderly patients – is it reasonable?
by: Fabian Bartsch, et al.
Published: (2019-10-01)

Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma
by: Tian-mei Zeng, et al.
Published: (2022-09-01)

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma
by: C. Peraldo-Neia, et al.
Published: (2018-06-01)

EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma
by: Xiao-Yi Hao, et al.
Published: (2016-07-01)

Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma
by: Chenwei Tang, et al.
Published: (2024-01-01)

The focus clinical research in intrahepatic cholangiocarcinoma
by: Yinghui Song, et al.
Published: (2022-07-01)

Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
by: Serifis N, et al.
Published: (2021-11-01)

Multi-omics integrated analyzed the origin of intrahepatic mucinous cholangiocarcinoma: a case report
by: Xiaokang Zeng, et al.
Published: (2023-07-01)

Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs
by: Li Zhang, et al.
Published: (2021-10-01)

New Insights into Surgical Management of Intrahepatic Cholangiocarcinoma in the Era of “Transplant Oncology”
by: Fabio Melandro, et al.
Published: (2023-09-01)

Vascular Resection for Intrahepatic Cholangiocarcinoma: Current Considerations
by: Ruslan Alikhanov, et al.
Published: (2021-08-01)

Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis
by: Dingan Luo, et al.
Published: (2021-10-01)

Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score
by: Imke Schatka, et al.
Published: (2022-10-01)